High-dose prophylactic anticoagulation or therapeutic anticoagulation reduced de novo thrombosis in patients with hypoxemic COVID-19 pneumonia, based on data from 334 adults. Patients with hypoxemic ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Two studies from New York City, the early epicenter of the COVID-19 pandemic in the United States, ...

Therapeutic-dose anticoagulation with heparins reduced 28-day mortality compared with prophylactic doses in patients hospitalized with COVID-19. Higher-dose anticoagulation was associated with a ...

Despite recommendations advising prophylactic anticoagulation in all hospitalized patients with SARS-CoV-2 infection, a significant proportion received none during some of the worst periods of the ...

NEW ORLEANS — A therapeutic vs. prophylactic dose of anticoagulation therapy did not significantly improve outcomes for noncritically ill patients hospitalized with COVID-19, though fewer therapeutic ...

High-dose anticoagulation can reduce deaths by 30 percent and intubations by 25 percent in hospitalized COVID-19 patients who are not critically ill when compared to the standard treatment, which is ...

The coagulopathy associated with SARS-CoV-2 infection encompasses both macrovascular and microvascular thromboses driven by endothelial injury, inflammation and platelet activation. Early recognition ...

(HealthDay News) — For patients hospitalized for COVID-19, administration of therapeutic-dose versus prophylactic-dose anticoagulation with heparins is associated with lower 28-day mortality, ...

NEW ORLEANS -- Full-dose anticoagulation failed to improve overall hard outcomes for non-intensive care unit (ICU) admissions for COVID-19 in the FREEDOM trial, but there was a signal for benefit ...

In a randomized trial, patients with moderately severe Covid-19 were assigned to receive either therapeutic-dose anticoagulation or usual-care thromboprophylaxis. At 21 days, therapeutic-dose ...

High-dose anticoagulation can reduce deaths by 30 percent and intubations by 25 percent in hospitalized COVID-19 patients who are not critically ill when compared to the standard treatment, which is ...